School of Pharmacy Publications

Browse Results (3767 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Page 49 of 76

Result Pages:    « first ‹ previous  39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58  next › last »

Refine

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Chan, V. and Tett, S.E. (2003). Pattern of disease modifying anti-rheumatic drug utilisation in Australia 1992-2002. In: Integrating research into practice. Annual Conference of APSA 2003, Bondi Beach, NSW, (3-3). 3-5 Dec. 2003. 35  
Staatz, Christine E., Smith, Alesha and Tett, Susan E. (2008). Pattern of mycophenolate prescribing in Australian kidney and cardiac transplant recipients. In: National Medicines Symposium 2008, Canberra, (). 14-16 May 2008. 48  
Hollingworth, Samantha A., Siskind, Dan J., Nissen, Lisa M., Robinson, Maxine and Hall, Wayne D. (2010) Patterns of antipsychotic medication use in Australia 2002-2007. Australian And New Zealand Journal of Psychiatry, 44 4: 372-377. doi:10.3109/00048670903489890 341   27 Cited 34 times in Scopus34 9
Bose, Utpal, Hodson, Mark P., Vidgen, Miranda E., Shaw, P. Nicholas, Fuerst, John A. and Hewavitharana, Amitha K. (2013). Patterns of chemical diversity on sponge associated marine bacteria. In: 9th Annual Conference of the Metabolomics Society: Full Abstracts. 9th Annual Conference of the Metabolomics Society, Glasgow, Scotland, U.K., (264-264). 1-4 July, 2013. 36  
Peeters, G., Tett, S. E., Duncan, E. L., Mishra, G. D. and Dobson, A. J. (2013). Patterns of Osteoporosis Medication Dispensing for Older Australian Women From 2002 to 2010: Influences of Publications, Guidelines, Marketing Activities and Policy. In: Annual European Congress of Rheumatology EULAR abstracts. EULAR 2013, Madrid, Spain, (294-294). 12 - 15 June 2013. doi:10.1136/annrheumdis-2013-eular.908 34   0 0
Dulla B., Kolli S.K., Chamakura U.R., Deora G.S., Raju R.R. and Pal M. (2014) Pd/C-mediated arylation followed by I2-catalyzed hydration strategy: Preparation of functionalized novel indanone derivatives. Synthetic Communications, 44 10: 1466-1474. doi:10.1080/00397911.2013.860554 29   1 Cited 1 times in Scopus1 0
Getachew, Robel, Ballinger, Mandy L., Burch, Micah L., Reid, Julianne J., Khachigian, Levon M., Wight, Thomas N., Little, Peter J. and Osman, Narin (2013) PDGF β-receptor kinase activity and ERK1/2 mediate glycosaminoglycan elongation on biglycan and increases binding to LDL. Endocrinology, 151 9: 4356-4367. doi:10.1210/en.2010-0027 63   19 Cited 21 times in Scopus21 0
Lum, E. P. M., La Caze, A. and Cutts, C. (2003). Peer group teleconferences: A rural strategy for enhancing quality prescribing?. In: 26th Federal Conference program handbook. SHPA 26th Federal Conference 2003, Canberra, (159-159). 13-16 Nov. 2003. 27  
Robinson, M. T. (2005) Pegatron: (Combination product of peginterferon (a2b) in a pen injector and ribavirin capsules). The New Drug Brief, 23 Aug. 1-5. 65  
Faridoon, Hussein, Waleed M., Islam, Nazar Ul, Guddat, Luke W., Schenk, Gerhard and McGeary, Ross P. (2012) Penicillin inhibitors of purple acid phosphatase. Bioorganic and Medicinal Chemistry Letters, 22 7: 2555-2559. doi:10.1016/j.bmcl.2012.01.123 65   1 Cited 2 times in Scopus2 0
Paz, Cristian, Becerra, Jose, Silva, Mario, Burgos, Viviana, Heydenreich, Matthias, Schmidt, Bernd, Thu Tran and Vetter, Irina (2015) (-)-Pentylsedinine, a new alkaloid from the leaves of lobelia tupa with agonist activity at nicotinic acetylcholine receptor. Natural Product Communications, 10 8: 1355-1357. 853 12 0
Khan, Saad A., Moorthy, Jayanthy, Omar, Hanan and Hasan, Syed Shahzad (2012) People living with HIV/AIDS (PLWHA) and HIV/AIDS associated oral lesions; a study in Malaysia. Bmc Public Health, 12 1: 850-1-850-8. doi:10.1186/1471-2458-12-850 34   1 Cited 2 times in Scopus2 1
Hunter, A. (2006) Peppermint: how cool is that?. Australian Pharmacist, 25 1: 50-50. 40  
Skwarczynski, Mariusz, Dougall, Annette M., Khoshnejad, Makan, Chandrudu, Saranya, Pearson, Mark S., Loukas, Alex and Toth, Istvan (2012) Peptide-Based Subunit Vaccine against Hookworm Infection. PLoS One, 7 10 Article #e46870: . doi:10.1371/journal.pone.0046870 60   12 Cited 14 times in Scopus14 0
Skwarczynski, Mariusz and Toth, Istvan (2016) Peptide-based synthetic vaccines. Chemical Science, 7 2: 842-854. doi:10.1039/c5sc03892h     1 0 6
Ahmad Fuaad, Abdullah A. H., Azmi, Fazren, Skwarczynski, Mariusz and Toth, Istvan (2013) Peptide conjugation via CuAAC 'click' chemistry. Molecules, 18 11: 13148-13174. doi:10.3390/molecules181113148 48   17 Cited 20 times in Scopus20 0
Goodwin, D., Simerska, P. and Toth, I. (2012) Peptides as therapeutics with enhanced bioactivity. Current Medicinal Chemistry, 19 26: 4451-4461. doi:10.2174/092986712803251548 75 2 30 Cited 37 times in Scopus37 0
Rostam, Muhamad A., Piva, Terrence J., Rezaei, Hossein B., Kamato, Danielle, Little, Peter J., Zheng, Wenhua and Osman, Narin (2015) Peptidyl-prolyl isomerases: functionality and potential therapeutic targets in cardiovascular disease. Clinical and Experimental Pharmacology and Physiology, 42 2: 117-124. doi:10.1111/1440-1681.12335 11   2 Cited 2 times in Scopus2 1
Barozzi, N. and Tett, S.E. (2007). Perceived barriers to acetaminophen prescribing, especially following rofecoxib withdrawal from the market. In: Abstracts : Fourth Canadian Therapeutics Congress. 4th Canadian Therapeutics Congress, Halifax, Nova Scotia, Canada, (e152-e152). 27-30 May 2007. 25  
Barozzi, N. and Tett, S. E. (2009) Perceived barriers to paracetamol (acetaminophen)prescribing, especially following rofecoxib withdrawal from the market. Clinical Rheumatology, 28 5: 509-519. doi:10.1007/s10067-008-1077-8 73   6 Cited 10 times in Scopus10 0
Hasan, Syed Shahzad, Wong. Pei Se, Ahmed, Syed Imran, Chong, David Weng Kwai, Mai, Chun Wai, Pook, Peter and Kairuz, Therese (2013) Perceived impact of clinical placements on students' preparedness to provide patient-centered care in Malaysia. Currents in Pharmacy Teaching and Learning, 5 4: 303-310. doi:10.1016/j.cptl.2013.01.010 64   0 0
Kyle, G. J., Nissen, L. M. and Tett, S. E. (2008) Perception of prescription medicine sample packs among Australian professional, government, industry, and consumer organizations, based on automated textual analysis of one-on-one interviews. Clinical Therapeutics, 30 12: 2461-2473. doi:10.1016/j.clinthera.2008.12.016 119   8 Cited 9 times in Scopus9 0
Babar, Muneer Gohar, Syed, Shahzad Hasan, Naing, Cho Min and Hamzah, Nur Hidayah Binti (2012) Perceptions and self-use of Complementary and Alternative Medicine (CAM) among Malaysian dental students. European Journal of Integrative Medicine, 4 1: E63-E69. doi:10.1016/j.eujim.2011.11.001 41   1 Cited 6 times in Scopus6 0
Bajramovic, Jasmina, Emmerton, Lynne and Tett, Susan E. (2004) Perceptions around concordance - focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners. Health Expectations, 7 3: 221-234. doi:10.1111/j.1369-7625.2004.00280.x 151   24 Cited 32 times in Scopus32 0
Bajramovic Fejzic, J., Emmerton, L. M. and Tett, S. E. (2004). Perceptions of concordance with medicines: Focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners. In: Maria Cordina, Social Pharmacy: Exploring theoretical and cultural perspectives. 13th International Social Pharmacy Workshop, Malta, (64-64). 19-23 July, 2004. 67  
Kairuz, Therese, Case, Sarah and Shaw, John (2007) Perceptions of graduates and preceptors regarding a new pharmacy programme. Pharmacy Education, 7 2: 151-157. doi:10.1080/15602210701275864 36   Cited 6 times in Scopus6 0
Cottrell, N., Emmerton, L. and Denaro, C. (2010). Perceptions of heart failure patients towards non-steroidal anti-inflammatory drugs. In: Abstract of the National Medicines Sympsium 2010: Medicines in people’s lives.. National Medicines Symposium 2010, Melbourne, VIC, Australia, (235-235). 26-28 May, 2010. 43  
Hall, Kristine B., Tett, Susan E. and Nissen, Lisa M. (2006) Perceptions of the influence of prescription medicine samples on prescribing by family physicians. Medical Care, 44 4: 383-387. doi:10.1097/01.mlr.0000204017.71426.53 175   21 Cited 22 times in Scopus22 0
Monteith, G. R. (1999) Performance enhancing drugs. Australian Pharmacist, 18 11: 654-658. 87  
Charles, B. G., Hussein, R., Morris, R.G. and Rasiah, R. L. (2001). Perhexiline population pharmacokinetics in refractory angina patients. In: K. Brosen, O.A. Medergaard and M. Orme, Clinical pharmacology - from molecule to society - bridging the gap via man. 5th Congress of European Assoc. for Clinical Pharmacology &Therapeutics, Odense, Denmark, (83-83). 12-15 Sept 2001. 96  
Charles, B. G., Hussein, R., Morris, R.G. and Rasiah, R. L. (2001). Perhexiline population pharmacokinetics in refractory angina using retrospective routine therapeutic drug monitoring data. In: S.J. Soldin and F. Sjoqvist, Abstracts - 7th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology. 7th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology, Washington DC, (493-493). 1-6 Sept 2001. 74  
Steer, P., Flenady, V., Gray, P., Shearman, A. D. and Charles, B. G. (2000). Periextubation caffeine for neonates born less than 30 weeks gestation: a randomised trial of two dosing regimens. In: Proceedings of 4th annual congress of Perinatal Society of Australia & New Zealand. 4th Annual Congress of PSANZ, Brisbane, Qld, Australia, (75-75). 12-15 March 2000. 75  
Steer, P.A., Flenady, V.J., Gray, P.H., Shearman, A.D., Henderson-Smart, D., Fraser, S., Bury, G. and Charles, B.G. (2000). Periextubation caffeine in neonates born less than 30 weeks gestation: A randomised trial of two dosing regimens. In: Unknown. Unknown, Unknown, (434A-434A). Unknown. 31   0
Steer, P. A., Flenady, V. J., Shearman, A., Lee, T. C., Tudehope, D. I. and Charles, B. G. (2003) Periextubation caffeine in preterm neonates: A randomized dose response trial. Journal of Paediatrics And Child Health, 39 7: 511-515. doi:10.1046/j.1440-1754.2003.00207.x 118   14 Cited 19 times in Scopus19 0
Hale, A. R., Coombes, I. D., Stokes, J., McDougall, D., Whitfield, K., Maycock, E. and Nissen, L. (2013) Perioperative medication management: Expanding the role of the preadmission clinic pharmacist in a single centre, randomised controlled trial of collaborative prescribing. BMJ Open, 3 7: . doi:10.1136/bmjopen-2013-003027 27   4 Cited 8 times in Scopus8 24
Varamini, Pegah, Goh, Wei Huang, Mansfeld, Friederike M., Blanchfield, Joanne T., Wyse, Bruce D., Smith, Maree T. and Toth, Istvan (2013) Peripherally acting novel lipo-endomorphin-1 peptides in neuropathic pain without producing constipation. Bioorganic & Medicinal Chemistry, 21 7: 1898-1904. doi:10.1016/j.bmc.2013.01.044 69   9 Cited 10 times in Scopus10 0
Faddy, H. M., Robinson, J. A., Holman, N. A., Monteith, G. R. and Roberts-Thomson, S. J. (2004). Peroxisome proliferator-activated receptor a in human breast cancer cell lines. In: Building a healthier future through research. 4th Annual Queensland Health and Medical Scientific Meeting, Brisbane, (264-264). 30 November - 1 December, 2004. 57  
Suchanek, K. M., Lee, W. J., May, F. J., Holman, N. A., Monteith, G. R. and Roberts-Thomson, S. J. (2001). Peroxisome proliferator-activated receptor alpha and beta characterization in human mammary gland epithelial cell lines. In: International Congress of Toxicology, Brisbane Australia, (93-93). 8-13 July 2001. 49   0
Faddy, H. M., Robinson, J. A., Lee, W. J., Holman, N. A., Monteith, G. R. and Roberts-Thomson, S. J. (2006) Peroxisome proliferator-activated receptor alpha expression is regulated by estrogen receptor alpha and modulates the response of MCF-7 cells to sodium butyrate. International Journal of Biochemistry & Cell Biology, 38 2: 255-266. doi:10.1016/j.biocel.2005.09.002 84   15 Cited 14 times in Scopus14 0
Suchanek, Kate M., May, Fiona J., Robinson, Jodie A., Lee, Won Jae, Holman, Nicola A., Monteith, Gregory R. and Roberts-Thomson, Sarah J. (2002) Peroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231. Molecular Carcinogenesis, 34 4: 165-171. doi:10.1002/mc.10061 90   79 Cited 84 times in Scopus84 0
Jeffery, B, Choudhury, AI, Horley, N, Bruce, M, Tomlinson, SR, Roberts, RA, Gray, TJB, Barrett, DA, Shaw, PN, Kendall, D and Bell, DR (2004) Peroxisome proliferator activated receptor alpha regulates a male-specific cytochrome P450 in mouse liver. Archives of Biochemistry And Biophysics, 429 2: 231-236. doi:10.1016/j.abb.2004.06.025 77   12 Cited 11 times in Scopus11 0
Suchanek, K. M., May, F. J., Lee, W. J., Holman, N. A. and Roberts-Thomson, S. J. (2002) Peroxisome proliferator-activated receptor beta expression in human breast epithelial cell lines of tumorigenic and non-tumorigenic origin. International Journal of Biochemistry & Cell Biology, 34 9: 1051-1058. doi:10.1016/S1357-2725(02)00025-0 56   26 Cited 25 times in Scopus25 0
Falconer, Caitlin, Monteith, Gregory R. and Roberts-Thomson, Sarah J. (2009). Peroxisome proliferator-activated receptor expression in the mouse mammary gland and human breast cancer cell lines. In: ASCEPT 43rd Annual Scientific Meeting 2009: The Rights of Medicines, Darling Harbour, NSW, Australia, (). 29 November-2 December 2009. 31  
Peiris, M., Monteith, G. R., Roberts-Thomson, S. J. and Cabot, P. J. (2006). Peroxisome-proliferator activated receptor (PPAR) beta/delta and its role inr elapsing-remitting experimental autoimmune encephalomyelitis (RR-EAE). In: Neuroscience 2006. Neuroscience 2006, Georgia World Congress Center / Altana, Georgia, U.S.A., (). 11-18 October, 2006. 83  
Lister, E. J., Faddy, H. M., Aung, C. S., Monteith, G. R. and Roberts-Thomson, S. J. (2005). Peroxisome proliferator activated receptor (PPAR) isoform expression during differentiation of HT-29 colon cancer cells. In: E. A. Davis and C. G. Sobey, Program & Abstracts: Joint Meeting of ASCEPT and APSA 2005. Joint Meeting of ASCEPT and APSA, Melbourne, Vic, Australia, (1-79-1-79). 4-7 December, 2005. 70  
Smith, S. A., Monteith, G. R. and Roberts-Thomson, S. J. (2002). Peroxisome proliferator-activated receptors in rat cerebellar granule neuronal cultures. In: Proceedings of the Society for Neuroscience 2002. Neuroscience 2002, Florida, (493-493). 2-7 Nov. 2002. 51  
Roberts-Thomson, S. J. (2000) Peroxisome proliferator-activated receptors in tumorigenesis: Targets of tumour promotion and treatment. Immunology And Cell Biology, 78 4: 436-441. doi:10.1046/j.1440-1711.2000.00921.x 64   60 Cited 70 times in Scopus70 0
Peiris, M., Monteith, G. R., Roberts-Thomson, S. J. and Cabot, P. J. (2006). Peroxisome-proliferator activated receptors modulate inflammation in relapsing-remitting experimental autoimmune encephalomyelitis. In: Combined Conference Abstracts: ComBio 2006. ComBio 2006, Brisbane Convention Centre, Brisbane, Australia, (178-178). 24-28 September, 2006. 55  
Roberts-Thomson, S. J., Robinson, J. A., Faddy, H. M., Holman, N. A., Davis, B.J., Gopisetty Venkata, N., Suchanek, K. M., May, F. J., Lee, W. J. and Monteith, G. R. (2003). Peroxisome proliferator-activated receptors (PPAR) and breast cancer. In: Annual Queensland Health & Medical Scientific Meeting. Annual Queensland Health & Medical Scientific Meeting 2003, Brisbane, Qld, Australia, (1-1). 25-26 November, 2003. 80  
Tan, Amy, Emmerton, Lynne and Hattingh, Laetitia (2012) Personal carers' role in medication administration: An exploratory study in a rural community in Queensland. The Australian Nursing Journal, 19 10: 31-31. 120 2 0

Page 49 of 76

Result Pages:    « first ‹ previous  39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58  next › last »